daunorubicin has been researched along with salicylates in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Britigan, BE; Burns, CP; Reszka, KJ; Spitz, DR; Teesch, LM; Wagner, BA | 1 |
| Gust, R; Henze, G; Hille, A; Jesse, P; Kitanovic, I; Lee, SY; Prokop, A; Wölfl, S | 1 |
| Berkessel, A; Dragoun, M; Frias, C; Günther, T; Prokop, A | 1 |
3 other study(ies) available for daunorubicin and salicylates
| Article | Year |
|---|---|
Inactivation of anthracyclines by cellular peroxidase.
Topics: Animals; Antibiotics, Antineoplastic; Biotransformation; Cell Line, Tumor; Daunorubicin; Doxorubicin; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Male; Myocytes, Cardiac; Oxidation-Reduction; Peroxidase; Phthalic Acids; Prostatic Neoplasms; Rats; Salicylates | 2005 |
[Fe(III)(salophene)Cl], a potent iron salophene complex overcomes multiple drug resistance in lymphoma and leukemia cells.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ferric Compounds; Humans; Leukemia; Lymphoma; Membrane Potential, Mitochondrial; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Salicylates; Vincristine | 2011 |
Metal-free salan-type compound induces apoptosis and overcomes multidrug resistance in leukemic and lymphoma cells in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia; Lymphoma; Neoplasms; Phenylenediamines; Salicylates; Vincristine | 2018 |